Houlihan Financial Resource Group, Ltd. Pfizer Inc Transaction History

Houlihan Financial Resource Group, Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $13,313 - $17,332	-338 Reduced 5.53%	5,775 $236,000
Q3 2022 Dec 13, 2022	SELL	$43.76 - $53.42 $19,254 - $23,504	-440 Reduced 6.71%	6,113 $285,000
Q3 2020 Nov 13, 2020	BUY	$31.75 - $37.25 $7,080 - $8,306	223 Added 3.52%	6,553 $252,000
Q1 2020 May 01, 2020	SELL	$27.03 - $38.62 $3,054 - $4,364	-113 Reduced 1.75%	6,330 $207,000
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $212,103 - $240,710	6,443 New	6,443 $252,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Houlihan Financial Resource Group, Ltd., based on Form 13F filings with the SEC.

Stay updated on Houlihan Financial Resource Group, Ltd. with notifications on news.